Helsinki — MediSapiens Ltd, a Finnish company developing bioinformatics

applications for the pharmaceutical industry, today announced that it will provide Bayer

HealthCare with a new software solution for analysis and visualization of genomics data.

This software system, called the Integrated Genomics Platform, will serve as a centralized access

to genomics data used throughout a research organization. The Integrated Genomics

Platform provides storage and access to a vast collection of clinical genomics data, coupled

with an extensive set of tools for analysis and visualization of the data.

“Data alone serves very little purpose. Without structure and proper means of interpretation,

it is merely numbers. And when we talk about genomics data, the sheer amount of it is

almost terrifying. The Integrated Genomics Platform will turn the vast pool of genomics data

into knowledge that can be used to drive decision making processes in pharmaceutical

research and development”, says Sami Kilpinen, CEO of MediSapiens Ltd.